ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- EBITDA, 2025
- $557M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $557M | — |
| 2024 | −$120M | — |
| 2023 | −$228M | — |
| 2022 | −$741M | — |
| 2021 | −$661M | — |
| 2020 | −$794M | — |
| 2019 | −$922M | — |
| 2018 | −$799M | — |
| 2017 | −$487M | — |
| 2016 | −$409M | — |
| 2015 | −$277M | — |
| 2014 | −$393M | — |
| 2013 | −$83M | — |
| 2012 | −$120M | — |
| 2011 | −$50M | — |
| 2010 | −$39M | — |
| 2009 | −$42M | — |
| 2008 | −$22M | — |